Previous 10 | Next 10 |
California State Court hands Endo and other opioid producers a temporary win in liability trial. Tentative ruling directs manufacturers to file a statement of decision within 30 days. Ruling likely takes away major liability in the country's biggest state at least for a while. ...
A recent tentative ruling in the California opioid trial in favor of the pharmaceutical manufacturers should catalyze a nationwide settlement. Teva is not completely out of the woods, but the California ruling takes bankruptcy risk off the table, in my view. From its current FCF y...
A legal victory took center stage in Tuesday's midday trading, sparking massive rallies in Teva Pharmaceutical Industries (NYSE:TEVA) and Endo International (NASDAQ:ENDP). A judge took the companies' side in a $50B case related to the opioid crisis. Fabrinet (NYSE:FN) was another major gainer...
Shares of Teva Pharmaceutical Industries (NYSE: TEVA) were jumping 7.1% as of 11:10 a.m. EDT on Tuesday. The solid gain came following a California court ruling yesterday in favor of Teva and three other drugmakers in opioid-related litigation filed by Orange, Los Angeles, and Santa...
California State Court Issues Tentative Ruling in Endo's Favor Following Opioid Trial PR Newswire DUBLIN , Nov. 2, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) ("Endo") today announced that, following a months-long trial, one of the f...
The State of Alabama has reached a settlement with Endo International (ENDP +8.7%) regarding the drugmaker's alleged role in the nation's prescription opioid epidemic, Reuters reports. Terms of the settlement were not immediately available. The disclosure was made in a court filing by McKesso...
TEVA stock is down irrationally after its quarterly earnings report. Shares traded at a 2021 forward P/E in the 3 times range. Outlook reaffirmed. For further details see: Five Considerations After Teva Pharmaceuticals' Q3 Report
Endo Announces First-Ever XIAFLEX® (collagenase clostridium histolyticum) Television Commercial, Bent Carrot, and Branded Campaign to Raise Awareness of Peyronie's Disease - XIAFLEX is the first and only FDA-approved treatment for Peyronie's disease (PD), a men's health con...
Endo Presents New XIAFLEX® (collagenase clostridium histolyticum) Data Analysis at Sexual Medicine Society of North America (SMSNA) Annual Meeting PR Newswire DUBLIN , Oct. 22, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today th...
Are These Penny Stocks On Your Buy or Sell List Right Now? When you’re looking for the best penny stocks to buy , there are plenty of things to review before pulling the trigger. At least, for most experienced traders, momentum and technical analysis are just a few parts of a...
News, Short Squeeze, Breakout and More Instantly...
Endo International plc Company Name:
ENDP Stock Symbol:
NASDAQ Market:
Endo International plc Website:
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Canada NewsWire DUBLIN , Sept. 21, 2023 /CNW/ -- Endo International plc (OTC:...
ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS Canada NewsWire DUBLIN , Aug. 8, 2023 /CNW/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the second-quarter ended June 30, 2023 . SECOND-QUARTER FINANCIAL PERF...
Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe Canada NewsWire The ready-to-use pre-filled syringe combines two well-known, FDA-approved product...